Results 221 to 230 of about 153,892 (355)

Increasing Prevalence of Syphilis: Oral Manifestations, Diagnosis and Management

open access: yesOral Surgery, Volume 18, Issue 3, Page 335-341, August 2025.
ABSTRACT Introduction Cases of syphilis are increasing, with 9513 cases diagnosed in England in 2023, the highest annual number since 1948. Oral healthcare professionals should therefore be aware of how oral syphilis presents, the differential diagnosis and the appropriate care pathway and management.
C. C. Currie   +8 more
wiley   +1 more source

Efficacy of losartan plus modified FOLFIRINOX versus modified FOLFIRINOX in advanced pancreatic cancers: A randomized clinical trial (AFPAC Study)

open access: yesCancer, Volume 131, Issue 13, 1 July 2025.
Abstract Background The addition of angiotensin receptor blockers like losartan (L) has been shown to improve outcomes in small prospective studies of pancreatic ductal adenocarcinomas (PDAC). Methods Patients diagnosed with treatment‐naive locally advanced/metastatic PDAC with Eastern Cooperative Oncology Group performance status 0‐1 and adequate end‐
Anant Ramaswamy   +15 more
wiley   +1 more source

Clinical Characteristics and Risk Factors of Geographic Tongue: A Retrospective Analysis of 100 Polish Patients. [PDF]

open access: yesHealthcare (Basel)
Ślebioda Z   +7 more
europepmc   +1 more source

High Cell Density Perfusion Process of Quail Cells Producing Oncolytic rVSV‐NDV

open access: yesEngineering in Life Sciences, Volume 25, Issue 7, July 2025.
ABSTRACT Oncolytic viruses as agents for the treatment of various types of cancer have demonstrated their potential in many clinical studies over the past decades. In particular, rVSV‐NDV (a recombinant vesicular stomatitis virus [VSV] construct with fusogenic Newcastle disease virus glycoproteins) shows promising preclinical results.
Lennart Jacobtorweihe   +5 more
wiley   +1 more source

Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374). [PDF]

open access: yesESMO Open
Gambardella V   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy